Cell Isolation/Cell Separation Market Worth $13.0 Billion by 2024 - Exclusive Report by MarketsandMarkets™

Cell Isolation/Cell Separation Market Worth $13.0 Billion by 2024 - Exclusive Report by MarketsandMarkets™

PR Newswire

CHICAGO, Feb. 20, 2019

CHICAGO, Feb. 20, 2019 /PRNewswire/ --According to the new market research report  "Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer), End User (Hospitals, Biotechnology) - Global Forecast to 2024", published by MarketsandMarkets™, the Cell Isolation Market is expected to reach USD 13.0 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 17.2%.


Don't miss out on business opportunities in Cell Isolation Market

The growth in this market is attributed to the increasing government funding for cell-based research, increasing number of patients suffering from cancer and infectious diseases, technological advancements, and the growing focus on personalized medicine.

Cell isolation consumables dominated the market in 2018.

On the basis of type, the Cell Isolation Market is segmented into consumables and instruments. In 2018, the consumables segment accounted for a larger share of the Cell Isolation Market. The dominant share of this segment can be attributed to the increasing investments by companies to develop technologically advanced products and the repetitive use of consumables.

Browse in-depth TOC on "Cell Isolation Market"

208 – Tables

45 – Figures  

195 – Pages  

Get 10% Free Customization on this Report: 


The centrifugation-based cell isolation technique is expected to hold the largest share of the market during the forecast period.

On the basis of technique, the Cell Isolation Market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. The centrifugation-based cell isolation segment is expected to account for the largest market share in 2018. This technique is used on a large scale by biotech and biopharmaceutical companies and its cost-effectiveness in both small-scale and large-scale operations is a major reason its dominant share.

Biotechnology & biopharmaceutical companies to hold the largest share of the market during the forecast period.

Based on end users, the Cell Isolation Market is segmented into research laboratories & institutes, hospitals & diagnostic laboratories, biotechnology & biopharmaceutical companies, and other end users. The biotechnology & biopharmaceutical companies segment accounted for the largest market share in 2018. The large share of this segment is attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology & biopharmaceutical companies and the increasing number of R&D facilities globally.

Inquiry Before Buying:


North America held the largest share of the market in 2018.

The Cell Isolation Market is segmented into four major geographic segments North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America commanded the largest share of the Cell Isolation Market, followed by Europe. The large share of the North American market is attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.

The major players in the Cell Isolation Market are Beckman Coulter (US), Becton Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Miltenyi Biotec (Germany), pluriSelect (Germany), STEMCELL Technologies Inc. (Canada), Terumo BCT (US), Thermo Fisher Scientific (US), and Bio-Rad Laboratories Inc. (US).

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-isolation-market.asp 
Visit Our Website: https://www.marketsandmarkets.com

Voltar noticias em Inglês